
Biotechnology investment firm that creates and funds therapeutics companies, including via its BioImpact arm

Venture investor backing early- to mid-stage life science companies, mainly in the US Midwest

Hopen Life Science Ventures is a venture investor in early- to mid-stage life science companies. Most of its activity is in the Midwest of the United States, a region it describes as short of capital.
Early- and mid-stage life science businesses, chiefly in the Midwest, though the second fund can invest anywhere in the country when the opportunity is strong.
Summary written by TrustList from the business's own published information, Oct 2026.
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Hopen Life Science Ventures.
Similar listings buyers compare against this one.

Biotechnology investment firm that creates and funds therapeutics companies, including via its BioImpact arm

A US venture capital firm focused on early-stage information technology and healthcare investments

PureTech Health is a biotherapeutics company that creates and advances new medicines through its own research engine

Grant-making programme that supported science-based startups where technology meets biology

Technology investor backing fast-growing, high-margin companies in fintech and other large markets

Healthcare-focused investment firm backing medical device, pharmaceutical, health IT and diagnostics companies

Technology venture fund investing in start-ups that come out of MIT, Harvard and the University of Rochester

Growth-capital manager offering tax-advantaged investment portfolios in technology, life sciences and renewable energy
Everything here links back to the same verified catalogue. Pick your next stop.